Form D — Alessa Therapeutics, Inc.
0001771653-25-000005 · filed 2025-05-01
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Total offering
- $31,616,096
- Total sold
- $25,376,457
- Minimum investment
- $1
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Alessa Therapeutics, Inc.
- CIK
- 1771653
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 930 BRITTAN AVENUE
SAN CARLOS, CA 94070 - Phone
- 650-223-5912
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Cam Gallagher · Executive OfficerSan Carlos, CA Find on LinkedIn ↗
-
Richard Lim · DirectorSan Carlos, CA Find on LinkedIn ↗
-
Annie Mitsak · DirectorSan Carlos, CA Find on LinkedIn ↗
-
Douglas Crawford · DirectorSan Carlos, CA Find on LinkedIn ↗
-
Pamela Munster · DirectorSan Carlos, CA Find on LinkedIn ↗
-
Steve Tregay · DirectorSan Carlos, CA Find on LinkedIn ↗
-
Zachary Collins · Executive OfficerSan Carlos, CA Find on LinkedIn ↗
View original on SEC EDGAR.